Research Output per year
Fingerprint Dive into the research topics where Jonathan M. Schwartz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 11 Similar Profiles
Hepatocellular Carcinoma
Medicine & Life Sciences
Hepatitis C
Medicine & Life Sciences
Liver Transplantation
Medicine & Life Sciences
Acute Liver Failure
Medicine & Life Sciences
End Stage Liver Disease
Medicine & Life Sciences
Hepacivirus
Medicine & Life Sciences
Liver
Medicine & Life Sciences
Fibrosis
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Publications 1994 2018
Model for end-stage liver disease and sodium velocity predicts overall survival in nonmetastatic hepatocellular carcinoma patients
Tang, J. Y., Ohri, N., Kabarriti, R., Aparo, S., Chuy, J. W., Goel, S., Schwartz, J. M., Kinkhabwala, M., Kaubisch, A. & Guha, C., Jan 1 2018, In : Canadian Journal of Gastroenterology and Hepatology. 2018, 5681979.Research output: Contribution to journal › Article
End Stage Liver Disease
Hepatocellular Carcinoma
Sodium
Survival
Mortality
Telementoring of primary care providers delivering hepatitis C treatment in New York City: Results from Project INSPIRE
Teixeira, P. A., Bresnahan, M. P., Laraque, F., Litwin, A. H., Shukla, S. J., Schwartz, J. M., Reynoso, S., Perumalswami, P. V., Weiss, J. M., Wyatt, B. & Schackman, B. R., Jan 1 2018, In : Learning Health Systems. 2, 3, e10056.Research output: Contribution to journal › Article
Open Access
Hepatitis C
Hepacivirus
Primary Health Care
Aptitude
Continuity of Patient Care
4
Citations
(Scopus)
Symptom distress in patients with end-stage liver disease toward the end of life
Hansen, L., Leo, M. C., Chang, M. F., Zaman, A., Naugler, W. & Schwartz, J. M., Aug 1 2015, In : Gastroenterology Nursing. 38, 3, p. 201-210 10 p.Research output: Contribution to journal › Article
End Stage Liver Disease
Psychology
Symptom Assessment
Emotions
Pain
Commentary: Real-world triple therapy experience treating hepatitis C virus - Authors' reply
Bichoupan, K., Schwartz, J. M., Martel-Laferriere, V., Giannattasio, E. R., Marfo, K., Odin, J. A., Liu, L. U., Schiano, T. D., Perumalswami, P., Bansal, M., Gaglio, P. J., Kalia, H. S., Dieterich, D. T., Branch, A. D. & Reinus, J. F., Mar 2014, In : Alimentary Pharmacology and Therapeutics. 39, 5, p. 543 1 p.Research output: Contribution to journal › Article
Oligopeptides
Ribavirin
Chronic Hepatitis C
Interferon-alpha
Hepacivirus
17
Citations
(Scopus)
Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir
Bichoupan, K., Schwartz, J. M., Martel-Laferriere, V., Giannattasio, E. R., Marfo, K., Odin, J. A., Liu, L. U., Schiano, T. D., Perumalswami, P., Bansal, M., Gaglio, P. J., Kalia, H. S., Dieterich, D. T., Branch, A. D. & Reinus, J. F., Jan 2014, In : Alimentary Pharmacology and Therapeutics. 39, 2, p. 209-216 8 p.Research output: Contribution to journal › Article
Hepatitis C
Fibrosis
Therapeutics
telaprevir
Blood Platelets